Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Dapagliflozin (Farxiga) and semaglutide (Ozempic) are both medications used to treat Type 2 diabetes and help lower the risk of heart problems in adults with heart disease. However, they belong to different medication classes and have distinct characteristics. Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor taken orally once a day, while semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist given as a subcutaneous (under the skin) injection once a week. Dapagliflozin is available in both brand-name and generic forms, whereas semaglutide is only available as a brand-name medication. Common side effects of dapagliflozin include urinary tract infections, yeast infections, and increased urination, while semaglutide can cause nausea, vomiting, and diarrhea. Dapagliflozin and semaglutide both have an increased risk of low blood sugar when combined with other diabetes medications.
Farxiga (dapagliflozin)
Ozempic (semaglutide)
Farxiga (dapagliflozin)
Ozempic (semaglutide)
Summary of Farxiga vs. Ozempic
Summary for SGLT2 inhibitor
Prescription only
Farxiga, the brand name for dapagliflozin, is used together with a nutritious diet and exercise plan to lower blood sugar levels in people 10 years and older with Type 2 diabetes. It can also help lower the risk of serious complications, hospitalization, and death in certain adults with heart failure or chronic kidney disease (CKD). Farxiga (dapagliflozin) belongs to the drug class called sodium-glucose cotransporter 2 (SGLT2) inhibitors. It's taken by mouth once a day. Some side effects include yeast infections, urinating more often, and weight loss.
Summary for GLP-1 agonist
Prescription only
Ozempic (semaglutide) is a GLP-1 agonist used with diet and exercise to help adults manage Type 2 diabetes. It can also lower the risk of heart attack, stroke, and heart-related death in some people with Type 2 diabetes. It comes as a once-weekly injection under the skin and as a tablet taken by mouth once a day. The injection is also approved to help slow worsening kidney problems in people with Type 2 diabetes and chronic kidney disease (CKD). Common side effects include nausea, vomiting, and diarrhea.
Indications of Farxiga vs. Ozempic
Indications for
•Type 2 diabetes (in addition to diet and exercise) in people age 10 and over
•Lowering the risk of hospitalization for heart failure in adults with Type 2 diabetes and heart disease
•Lowering the risk of hospitalization and death due to heart problems in people with heart failure
•Lowering the risk of worsening kidney problems, hospitalization for heart failure, and death due to heart problems in adults with chronic kidney disease (CKD)